Director at GeoVax (GOVX) receives 6,000-share stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GeoVax Labs, Inc. director Randal D. Chase received a grant of stock options covering 6,000 shares of common stock. The options carry an exercise price of $1.18 per share, become exercisable on June 17, 2027, and expire on June 17, 2036. Following this award, he holds 6,000 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
CHASE RANDAL D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 6,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 6,000 shares (Direct, null)
Footnotes (1)
Key Figures
Options granted: 6,000 options
Exercise price: $1.18 per share
Shares underlying options: 6,000 shares
+2 more
5 metrics
Options granted
6,000 options
Stock option award to director
Exercise price
$1.18 per share
Conversion or exercise price for options
Shares underlying options
6,000 shares
Underlying common stock
Exercise date
June 17, 2027
Options become exercisable
Expiration date
June 17, 2036
Options lapse if unexercised
Key Terms
Stock Option, conversion or exercise price, expiration date, underlying security, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
conversion or exercise price financial
"conversion_or_exercise_price: "1.1800""
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
What insider transaction did GeoVax (GOVX) disclose in this Form 4?
GeoVax disclosed that director Randal D. Chase received a grant of stock options for 6,000 shares of common stock. These options were awarded as compensation and do not represent an open-market purchase or sale of existing shares.
How many GeoVax (GOVX) options were granted to the director?
The director was granted stock options covering 6,000 shares of GeoVax common stock. This entire amount is reflected as held following the transaction, indicating the award increased his derivative holdings by the full 6,000 options.
What is the exercise price of the GeoVax (GOVX) stock options granted?
The granted GeoVax stock options have an exercise price of $1.18 per share. This is the price at which the director can purchase common shares upon exercising the options during the specified exercise period.
When do the newly granted GeoVax (GOVX) options become exercisable?
The stock options granted to the GeoVax director become exercisable on June 17, 2027. Before that exercise date, the options cannot be converted into common stock, so they function as a future right rather than current share ownership.
What is the expiration date of the GeoVax (GOVX) stock options?
The stock options granted to the GeoVax director expire on June 17, 2036. After this expiration date, any unexercised options will lapse, and the right to purchase common shares at $1.18 per share will end.